National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Quick Links
Director's Corner

Dictionary of Cancer Terms

NCI Drug Dictionary

Funding Opportunities

NCI Publications

Advisory Boards and Groups

Science Serving People

Español
NCI Highlights
High Dose Chemotherapy Prolongs Survival for Leukemia

Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E

Past Highlights
   
 
Results: 1 -7 of 7         results per page
View Search Criteria | Help With Results
           

1.

Phase
Type
Status
Age
Sponsor
Protocol IDs

Phase III


Educational/Counseling/Training, Screening, Treatment


Active


65 and over


Other


IRB00000063
NCT00379743

Last Modified: 5/29/2008     First Published: 3/6/2008  

2.

Phase
Type
Status
Age
Sponsor
Protocol IDs

Phase II


Educational/Counseling/Training, Screening


Active


35 to 64


NCI


TATA-1900215717A1
1900215717A1, NCT00632047


3.

Phase
Type
Status
Age
Sponsor
Protocol IDs

Phase II


Screening


Approved-not yet active


18 and over


Other


PRD 0801
CUMC AAD1382, NCT00702208


4.

Phase
Type
Status
Age
Sponsor
Protocol IDs

No phase specified


Biomarker/Laboratory analysis, Screening


Active


18 to 80


Other


9100208476
NCT00155792


5.

Phase
Type
Status
Age
Sponsor
Protocol IDs

No phase specified


Educational/Counseling/Training, Health services research, Screening


Approved-not yet active


21 and over


Other


RA-2006-025
NCT00379782


6.

Phase
Type
Status
Age
Sponsor
Protocol IDs

No phase specified


Diagnostic, Educational/Counseling/Training, Screening


Active


Not specified


Other


1A0CMS300067
NCT00380055


7.

Phase
Type
Status
Age
Sponsor
Protocol IDs

No phase specified


Health services research, Screening


Active


25 to 69


Other


H06-04032
NCT00461760

   
   

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov